Form S-3ASR AERIE PHARMACEUTICALS

Go back to Form S-3ASR AERIE PHARMACEUTICALS

Aerie Pharma (AERI) Prices Larger $75M Stock Offering at $29.50/Share

September 16, 2016 6:31 AM EDT

Aerie Pharmaceuticals, Inc. (Nasdaq: AERI) announced the pricing of a registered underwritten public offering of $75 million of shares of its common stock at a price to the public of $29.50 per share, before deducting underwriting discounts and commissions and other estimated offering expenses. The offering was upsized by $25 million over the offering amount anticipated to be sold as previously announced. This is in addition to $50 million raised separately through the completion and full utilization of an at-the-market (ATM) program with Cantor Fitzgerald & Co. filed prior to market open on September 15, 2016. Total... More

Aerie Pharma (AERI) Announces $50M Common Stock Offering

September 15, 2016 4:06 PM EDT

Aerie Pharmaceuticals, Inc. (Nasdaq: AERI) announced that it has commenced a registered underwritten public offering of $50 million of shares of its common stock.

Cantor Fitzgerald & Co. is acting as the sole underwriter for the offering.

Aerie intends to use the net proceeds of the offering for general corporate purposes, including the complete... More

Aerie Pharma (AERI) Files Common Stock Shelf

September 15, 2016 4:05 PM EDT

Aerie Pharma (NASDAQ: AERI) filed a registration with the U.S. SEC to sell shares of its common stock.

... More